Evogene Overview

  • Founded
  • 1999
Founded
  • Status
  • Public
  • Employees
  • 149
Employees
  • Stock Symbol
  • EVGN
Stock Symbol
  • Share Price
  • $3.74
  • (As of Thursday Closing)

Evogene General Information

Description

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment.

Contact Information

Website
www.evogene.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Agricultural Chemicals
Stock Exchange
TAE
Primary Office
  • P.O. Box 4173
  • Ness Ziona 7414003
  • Israel
+972 00-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Evogene Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.74 $3.96 $0.93 - $10.29 $151M 40.4M 140K -$0.75

Evogene Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 150,825 140,926 247 (4,736)
Revenue 1,298 1,040 753 1,747
EBITDA (21,581) (22,087) (16,779) (20,175)
Net Income (23,748) (23,374) (18,112) (20,758)
Total Assets 92,778 71,915 71,364 58,694
Total Debt 2,350 2,440 2,971 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Evogene Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Evogene‘s full profile, request access.

Request a free trial

Evogene Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based ind
Drug Discovery
Ness Ziona, Israel
149 As of 2020
00000
000000000 00000

00000

ore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui offi
000000000000000
Leverkusen, Germany
000000 As of 0000
00.00
0000 0000-00-00
000000000 00.00

000000

ncididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullam
000000000000 000000000
Melbourne, Australia
0000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Evogene Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bayer Corporation Leverkusen, Germany 000000 00.00 000000000 00.00
000000 Corporation Melbourne, Australia 0000 00000 000000000 00000
000000 000 0000000 Corporation Bangalore, India 00 0000 000000000 0000
000 000000000000 Corporate Backed or Acquired Indianapolis, IN 0000 000000000000
To view Evogene’s complete competitors history, request access »

Evogene Executive Team (12)

Name Title Board Seat Contact Info
Ofer Haviv Chief Executive Officer & President
Elran Haber Chief Executive Officer
Dorit Kreiner Chief Financial Officer, Finance
Eyal Emmanuel Chief Scientific Officer
Gadi Ben Nissim Executive Vice President, Corporate Development
You’re viewing 5 of 12 executive team members. Get the full list »

Evogene Board Members (13)

Name Representing Role Since
Leon Recanati Self Board Member 000 0000
Martin Gerstel Self Chairman & Board Member 000 0000
Oded Shoseyov Ph.D Self Board Member 000 0000
Sarit Firon Self Board Member 000 0000
Ziv Kop Self Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Evogene Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial